ACROBIOSYSTEMS CO.,LTD. — Investor Relations & Filings
ACROBIOSYSTEMS CO.,LTD. is a global biotechnology company specializing in the development and manufacturing of high-quality recombinant proteins and critical reagents for the life sciences industry. The company provides a comprehensive portfolio of products designed to accelerate the development of target therapeutics, including antibodies, cell and gene therapies, and vaccines. Key offerings include a wide range of biotinylated proteins, enzymes, and assay kits characterized by high bioactivity and batch-to-batch consistency. ACROBIOSYSTEMS supports drug discovery and clinical development through specialized platforms for protein engineering and characterization. Its products serve a diverse client base of pharmaceutical companies, biotechnology firms, and academic research institutions worldwide, focusing on therapeutic areas such as oncology, immunology, and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于回购公司股份的进展公告 | 2025-08-04 | Chinese | |
| 关于控股股东、实际控制人及其一致行动人持股比例被动触及1%整数倍的权益变动提示性公告 | 2025-07-14 | Chinese | |
| 2024年年度权益分派实施公告 | 2025-07-03 | Chinese | |
| 关于回购公司股份的进展公告 | 2025-07-02 | Chinese | |
| 深圳市他山企业管理咨询有限公司关于北京百普赛斯生物科技股份有限公司2022年限制性股票激励计划作废部分限制性股票事项的独立财务顾问报告 | 2025-06-24 | Chinese | |
| 关于调整回购股份价格上限的公告 | 2025-06-24 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44580700 | 关于回购公司股份的进展公告 | 2025-08-04 | Chinese | ||
| 44580690 | 关于控股股东、实际控制人及其一致行动人持股比例被动触及1%整数倍的权益变动提示性公告 | 2025-07-14 | Chinese | ||
| 44580676 | 2024年年度权益分派实施公告 | 2025-07-03 | Chinese | ||
| 44580665 | 关于回购公司股份的进展公告 | 2025-07-02 | Chinese | ||
| 44580657 | 深圳市他山企业管理咨询有限公司关于北京百普赛斯生物科技股份有限公司2022年限制性股票激励计划作废部分限制性股票事项的独立财务顾问报告 | 2025-06-24 | Chinese | ||
| 44580640 | 关于调整回购股份价格上限的公告 | 2025-06-24 | Chinese | ||
| 44580624 | 第二届监事会第十八次会议决议公告 | 2025-06-24 | Chinese | ||
| 44580614 | 上海市通力律师事务所关于北京百普赛斯生物科技股份有限公司2022年限制性股票激励计划作废部分已授予尚未归属的限制性股票相关事项之法律意见书 | 2025-06-24 | Chinese | ||
| 44580571 | 关于作废部分已授予但尚未归属的限制性股票的公告 | 2025-06-24 | Chinese | ||
| 44580556 | 第二届董事会第十九次会议决议公告 | 2025-06-24 | Chinese | ||
| 44580545 | 上海荣正企业咨询服务（集团）股份有限公司关于北京百普赛斯生物科技股份有限公司2025年股票增值权激励计划授予相关事项之独立财务顾问报告 | 2025-06-12 | Chinese | ||
| 44580535 | 2025 年第二次临时股东大会决议公告 | 2025-06-12 | Chinese | ||
| 44580525 | 上海君澜律师事务所关于北京百普赛斯生物科技股份有限公司2025年股票增值权激励计划向激励对象授予股票增值权之法律意见书 | 2025-06-12 | Chinese | ||
| 44580516 | 关于向2025年限制性股票激励计划激励对象首次授予限制性股票的公告 | 2025-06-12 | Chinese | ||
| 44580492 | 2025年股票增值权激励计划授予激励对象名单（授予日） | 2025-06-12 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ACROBIOSYSTEMS CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56034/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56034 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56034 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56034 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56034}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ACROBIOSYSTEMS CO.,LTD. (id: 56034)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.